1.- Bradley M. and Schumann B. Estudio de la orina. En: Bernard J Threatte G. (eds). Diagnóstico y tratamiento clínico para laboratorio. 4ta. Ed. España: Salvat Editores; 1992: 471-568.

2.- Hess B. Nutritional aspects of stone disease. Endocrinol Metab Clin North Am. 2002.Dec; 31(4):1017-1030

3.- Hess B, Ryall RL, Kavanagh JP, Khan SR, Kok DJ, Rodgers AL. and Tiseleus HG. Methods for measuring crystallization in urolithiasis research: why, how and when? Eur Urol 2001 Aug; 40(2):220-230

4.- Peter Pletka. Nefrolitiasis. En: Burton David Rose (eds). Fisiopatología de las Enfermedades Renales. 1ra Edición. Mc Graw-Hill 1985: pag 696.

5.- Robertson WG. Renal stone in the tropics. Semin Nephrol 2003 Jan; 23(1):77-87.

6.- Schepers MS, van der Boom BG, Romijin JC, Schrôder FH. and Verkoelen CF. Urinary crystallization inhibitors do not prevent crystal binding. J Urol 2002 Apr; 167 (4):1844-1847)

7.- Tsujihata M, Miyake O, Yoshimura K, Kakimoto K, Takahara S. and Okuyama A. Comparison of fibronectin content in urinary macromolecules between normal subjects and recurrent stone formers. Eur Urol 2001.Oct; 40(4):458-462.

8.- Wiessner JH, Hung LY and Mandel NS. Crystal attachment to injured renal collecting duct cells: influence of urine proteins and pH. Kidney Internat 2003. Apr; 63(4):1313.1320